These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4391942)

  • 1. The efficacy of antiarrhythmic drugs in the prevention of recurrence of aconitine-induced atrial fibrillation after electrical conversion.
    Byrne JE; Dresel PE
    Can J Physiol Pharmacol; 1970 Feb; 48(2):90-7. PubMed ID: 4391942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relative effectiveness of various antiarrhythmia drugs in experimental aconitine arrhythmia].
    Vrbovský L
    Bratisl Lek Listy; 1971; 56(6):669-80. PubMed ID: 5157092
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K; Oshima T; Kumakura S; Hashimoto K
    Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of quinidine, propranolol and diphenylhydantoin for preventing recurrence in post-cardioversion auricular fibrillation].
    Cuan Pérez M; Ortiz A
    Arch Inst Cardiol Mex; 1971; 41(3):278-84. PubMed ID: 5566599
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of new anti-arrhythmic agents.
    Sano T; Suzuki F; Sato S; Iida Y
    Jpn Heart J; 1968 Mar; 9(2):161-8. PubMed ID: 5302316
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition and management of supraventricular tachyarrhythmias.
    Tonkin A
    Aust N Z J Med; 1981 Dec; 11(6):697-705. PubMed ID: 6949547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-cardioversion drug therapy in cases of atrial fibrillation.
    Thakur AK; Shreenivas
    J Indian Med Assoc; 1974 Sep; 63(5):145-50. PubMed ID: 4448913
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct current shock and antidysrhythmic drugs.
    Szekely P; Wynne NA; Pearson DT; Batson GA; Sideris DA
    Br Heart J; 1970 Mar; 32(2):209-18. PubMed ID: 5440516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular tachycardia.
    Willerson JT; Yurchak PM; DeSanctis RW
    Cardiovasc Clin; 1970; 2(2):69-86. PubMed ID: 4131129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP].
    Veloso HH; de Paola AA
    Arq Bras Cardiol; 1998 Jan; 70(1):43-9. PubMed ID: 9629687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
    Koenig A; Theolade R; Chauvin M; Brechenmacher C
    Presse Med; 1993 Nov; 22(36):1827-32. PubMed ID: 8309912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation.
    Sloan RW; Zervanos NJ; Snyder RL; Zurad EG
    J Fam Pract; 1986 Jan; 22(1):25-7, 30-4, 36. PubMed ID: 3941299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.